Anixa Biosciences
ANIX
53 hedge funds and large institutions have $12.3M invested in Anixa Biosciences in 2024 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 10 closing their positions.
20% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 10
0.82% more ownership
Funds ownership: 16.56% → 17.39% (+0.82%)
9% less funds holding
Funds holding: 58 → 53 (-5)
25% less capital invested
Capital invested by funds: $16.5M → $12.3M (-$4.19M)
50% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
+$2.09M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$284K |
| 3 |
RSWM
Robertson Stephens Wealth Management
San Francisco,
California
|
+$72.7K |
| 4 |
AWS
Atria Wealth Solutions
New York
|
+$68.1K |
| 5 |
CAM
Concorde Asset Management
Ann Arbor,
Michigan
|
+$39.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$648K |
| 2 |
Jane Street
New York
|
-$380K |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$265K |
| 4 |
Renaissance Technologies
New York
|
-$215K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$119K |
ANIX Hedge Fund Activity: Q2 2024 in Review
53 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Anixa Biosciences (ANIX) for Q2 2024, worth a combined $12.3M — down 25% from $16.5M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of ANIX and 5 opened new positions — a net loss of 5 holders — while 10 trimmed existing stakes and 12 added.
The largest buyer was D.A. Davidson & Co, opening a new position worth an estimated $2.09M. The largest seller was Susquehanna International Group, cutting an estimated $648K.
- 53 institutional investors held Anixa Biosciences (ANIX) as of Q2 2024, down from 58 in Q1 2024.
- Funds reported $12.3M of Anixa Biosciences stock for Q2 2024, down 25% quarter-over-quarter.
- 5 funds opened new Anixa Biosciences positions in Q2 2024 and 10 closed out, a net change of -5 holders.
- The largest Anixa Biosciences buyer in Q2 2024 was D.A. Davidson & Co, an estimated $2.09M added.
- The largest Anixa Biosciences seller in Q2 2024 was Susquehanna International Group, an estimated $648K sold.
Based on aggregated 13F filings for Q2 2024.